Long-Term Complications of Preeclampsia

Seminars in Nephrology

Volumn 31, Issue 1, 2011, Pages 111-122

  Williams, David ^a  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

Cardiovascular; Diabetes; Hypertension; Metabolic syndrome; Preeclampsia

Indexed keywords

ARTICLE; CARDIOVASCULAR RISK; CLINICAL FEATURE; DIABETES MELLITUS; DYSLIPIDEMIA; ECLAMPSIA; ENDOTHELIAL DYSFUNCTION; GESTATIONAL AGE; HIGH RISK POPULATION; HUMAN; HYPERTENSION; INTRAUTERINE GROWTH RETARDATION; KIDNEY DISEASE; LIVER NECROSIS; MATERNAL HYPERTENSION; MEMORY DISORDER; MENTAL HEALTH; METABOLIC SYNDROME X; NEOPLASM; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PREECLAMPSIA; PREGNANCY COMPLICATION; PREMATURE LABOR; PRIORITY JOURNAL; PROTEINURIA; RISK ASSESSMENT; SEIZURE; THYROID DISEASE; VENOUS THROMBOEMBOLISM;

CARDIOVASCULAR DISEASES; DYSLIPIDEMIAS; ECLAMPSIA; FEMALE; FETAL GROWTH RETARDATION; HUMANS; KIDNEY DISEASES; MENTAL HEALTH; METABOLIC SYNDROME X; NEOPLASMS; OBSTETRIC LABOR, PREMATURE; PARITY; PRE-ECLAMPSIA; PREGNANCY; RISK; THYROID DISEASES; VENOUS THROMBOEMBOLISM;

EID: 78751700430     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2010.10.010     Document Type: Article

References (80)

1. Williams D.J. Physiology of healthy pregnancy. Oxford textbook of medicine 2003, Oxford University Press, Oxford. 5th ed. D.A. Warrell, T.M. Cox, J.D. Firth (Eds.).
2. Williams D. Pregnancy: a stress test for life. Curr Opin Obstet Gynecol 2003, 15:465-471.
3. Wallis A.B., Saftlas A.F., Hsia J., Atrash H.K. Secular trends in the rates of preeclampsia, eclampsia, and gestational hypertension, United States, 1987-2004. Am J Hypertens 2008, 21:521-526.
4. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000, 183:S1-S22. Anonymous.
5. David G.K., MacKenzie C., Brown M.A., et al. Predicting transformation fom gestational hypertension to preeclampsia in clinical practice: a possible role for 24 hour ambulatory blood pressure monitoring. Hypertens Pregnancy 2007, 26:77-87.
6. Xiong X., Demianczuk N.N., Buekens P., Saunders L.D. Association of preeclampsia with high birth weight for gestational age. Am J Obstet Gynecol 2000, 183:148-155.
7. Magee L.A., Yong P.J., Espinosa V., et al. Expectant management of severe preeclampsia remote from term: a structured systematic review. Hypertens Pregnancy 2009, 28:312-347.
8. Smith G.C.S., Pell J.P., Walsh D. Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129290 births. Lancet 2001, 357:1213-1216.
9. Ray J.G., Vermeulen M.J., Schull M.J., Redelmeier D.A. Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study. Lancet 2005, 366:1797-1803.
10. Irgens H.U., Reisaeter L., Irgens L.M., Lie R.T. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. BMJ 2001, 323:1213-1217.
11. Sattar N., Greer I.A. Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening. BMJ 2002, 325:157-160.
12. Seely E.W., Solomon C.G. Insulin resistance and its potential role in pregnancy-induced hypertension. J Clin Endocrinol Metab 2003, 88:2393-2398.
13. Bosio P.M., McKenna P.J., Conroy R., O'Herlihy C. Maternal central hemodynamics in hypertensive disorders of pregnancy. Obstet Gynecol 1999, 94:978-984.
14. Greer I.A. Thrombosis in pregnancy: maternal and fetal issues. Lancet 1999, 10:1258-1265.
15. Redman C.W., Sacks G.P., Sargent I.L. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999, 180:499-506.
16. Kuhl C. Insulin secretion and insulin resistance in pregnancy and GDM: implications for diagnosis and management. Diabetes 1991, 40:18-24.
17. Martin U., Davies C., Hayavi S., et al. Is normal pregnancy atherogenic? Clin Sci (Lond) 1999, 96:421-425.
18. Sattar N., Bedomir A., Berry C., et al. Lipoprotein subfraction concentrations in preeclampsia: pathogenic parallels to atherosclerosis. Obstet Gynecol 1997, 89:403-408.
19. Hubel C.A., Lyall F., Weissfeld L., et al. Small low-density lipoproteins and vascular cell adhesion molecules (VCAM-1) are increased in association with hyperlipidaemia in preeclampsia. Metabolism 1998, 47:1281-1288.
20. Magnussen E.B., Vatten L.J., Lund-Nilsen T.I., Salvesen K.A., Davey Smith G., Romundstad P.R. Prepregnancy cardiovascular risk factors as predictors of pre-eclampsia: population based cohort study. BMJ 2007, 335:978.
21. Mello G., Parretti E., Marozio L., et al. Thrombophilia is significantly associated with severe preeclampsia: results of a large-scale, case controlled study. Hypertension 2005, 46:1270-1274.
22. Sibai B.M., Ewell M., Levine R.J., et al. Risk factors associated with preeclampsia in healthy nulliparous women. Am J Obstet Gynecol 1997, 177:1003-1010.
23. O'Brien T.E., Ray J.G., Chan W.S. Maternal body mass index and the risk of preeclampsia: a systematic overview. Epidemiology 2003, 14:368-374.
24. Ray J.G., Diamond P., Singh G., Bell C.M. Brief overview of maternal triglycerides as risk factor for pre-eclampsia. BJOG 2006, 113:379-386.
25. Chappell L.C., Enye S., Seed P., et al. Adverse perinatal outcomes and risk factors for preeclampsia in women with chronic hypertension: a prospective study. Hypertension 2008, 51:1002-1009.
26. Innes K.E., Wimsatt J.H., McDuffie R. Relative glucose tolerance and subsequent development of hypertension in pregnancy. Obstet Gynecol 2001, 97:905-910.
27. Burton G.J., Woods A.W., Jauniaux E., Kingdom J.C. Heological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy. Placenta 2009, 30:473-482.
28. Levine R.J., Lam C., Qian C., et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 2006, 355:992-1005.
29. Levine R.J., Qian C., Maynard S.E., et al. Serum sFlt-1 concentration during preeclampsia and mid-trimester blood pressure in healthy nulliparous women. Am J Obstet Gynecol 2006, 194:1034-1041.
30. Ferrazzani S., De Carolis S., Pomini F., Testa A.C., Mastromarino C., Caruso A. The duration of hypertension in the puerperium of preeclamptic women: relationship with renal impairment and week of delivery. Am J Obstet Gynecol 1994, 171:506-512.
31. Chambers J.C., Fusi L., Malik I.S., et al. Association of maternal endothelial dysfunction with preeclampsia. JAMA 2001, 285:1607-1612.
32. Chesley L.C., Annitto J.E., Cosgrove R.A. The remote prognosis of eclamptic women. Sixth periodic report. Am J Obstet Gynecol 1976, 124:446-459.
33. Bellamy L., Casas J.P., Hingorani A.D., Williams D.J. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: a systematic review and meta-analysis. BMJ 2007, 335:974-977.
34. McDonald S.D., Malinowski A., Zhou Q., Yusuf S., Devereaux P.J. Cardiovascular sequleae of preeclampsia/eclampsia: a systematic review and meta-analyses. Am Heart J 2008, 156:918-930.
35. Magnussen E.B., Vatten L.J., Davey Smith G., Romundstad P.R. Hypertensive disorders in pregnancy and subsequently measured cardiovascular risk factors. Obstet Gynecol 2009, 114:961-970.
36. Ness R.B., Harris T., Cobb J., et al. Number of pregnancies and the subsequent risk of cardiovascular disease. N Engl J Med 1993, 328:1528-1533.
37. Lawlor D.A., Emberson J.R., Ebrahim S., et al. Is the association between parity and coronary heart disease due to biological effects of pregnancy or adverse lifestyle risk factors associated with child rearing? Findings from the British Women's Heart and Health Study and the British Regional Heart Study. Circulation 2003, 107:1260-1264.
38. Villamor E., Cnattingius S. Interpregnancy weight change and risk of adverse pregnancy outcomes: a population-based study. Lancet 2006, 368:1164-1170.
39. Chesley L.C. Hypertension in pregnancy: definitions, familial factor, and remote prognosis. Kidney Int 1980, 18:234-240.
40. Bryans C.I. The remote prognosis in toxaemia of pregnancy. Clin Obstet Gynecol 1966, 9:973-990.
41. Fisher K.A., Luger A., Spargo B.H., Lindheimer M.D. Hypertension in pregnancy: Clinical-pathological correlations and remote prognosis. Medicine 1981, 60:267-276.
42. Sibai B.M., el-Nazer A., Gonzalez-Ruiz A. Severe preeclampsia-eclampsia in young primigravid women: subsequent pregnancy outcome and remote prognosis. Am J Obstet Gynecol 1986, 155:1011-1016.
43. Sibai B.M., Sarinoglu C., Mercer B.M. Eclampsia. VII. Pregnancy outcome after eclampsia and long-term prognosis. Am J Obstet Gynecol 1992, 166:1757-1761.
44. Marin R., Gorostidi M., Portal C.G., et al. Long-term prognosis of hypertension in pregnancy. Hypertens Pregnancy 2000, 19:199-209.
45. Kaaja R., Poyhonen-Alho M.K. Insulin resistance and sympathetic overactivity in women. J Hypertens 2006, 24:131-141.
46. Spaan J.J., Ekhart T., Spaanderman M.E.A., Peeters L.L.H. Remote hemodynamics and renal function in formerly preeclamptic women. Obstet Gynecol 2009, 113:853-859.
47. Laivuoria H., Tikkanen M.J., Ylikorkala O. Hyperinsulinaemia 17 years after pre-eclamptic first pregnancy. J Clin Endocrinol Metab 1996, 81:538-542.
48. Hubel C.A., Snaedal S., Ness R.B., et al. Dyslipoproteinaemia in postmenopausal women with a history of eclampsia. BJOG 2000, 107:776-784.
49. Libby G., Murphy D.J., McEwan N.F., et al. Pre-eclampsia and the later development of type 2 diabetes in mothers and their children: an intergenerational study from the Walker cohort. Diabetologia 2007, 50:523-530.
50. Pouta A., Hartikainen A.-L., Sovio U., et al. Manifestations of metabolic syndrome after hypertensive pregnancy. Hypertension 2004, 43:825-831.
51. Carr D.B., Newton K.M., Utzschneider K.M., et al. Preeclampsia and risk of developing subsequent diabetes. Hypertens Pregnancy 2009, 28:435-447.
52. McDonald S.D., Han Z., Walsh M.W., et al. Kidney disease after preeclampsia: a systematic review and meta-analysis. Am J Kidney Dis 2010, 55:1026-1039.
53. Valdes G., Quezada F., Marchant E., et al. Association of remote hypertension in pregnancy with coronary artery disease: a case-control study. Hypertension 2009, 53:733-738.
54. Vikse B.E., Irgens L.M., Bostad L., Iversen B.M. Adverse perinatal outcome and later kidney biopsy in the mother. J Am Soc Nephrol 2006, 17:837-845.
55. Arnddottir G.A., Geirsson R.T., Arngrimsson R., et al. Cardiovascular death in women who had hypertension in pregnancy: a case control study. BJOG 2005, 112:286-292.
56. Bennett W.L., Gilson M.M., Jamshidi R., et al. Impact of bariatric surgery on hypertensive disorders in pregnancy: retrospective analysis of insurance claims data. BMJ 2010, 340:c1662.
57. Vogel J.A., Franklin B.A., Zalesin K.C., et al. Reduction in predicted coronary heart disease risk after substantial weight reduction after bariatric surgery. Am J Cardiol 2007, 99:222-226.
58. Williams D. Pregnancy: a stress test for life. Curr Opin Obstet Gynecol 2003, 15:465-471.
59. Gordin D., Hiilesmaa V., Fageruddd J., et al. Pre-eclampsia but not pregnancy-induced hypertension is a risk factor for diabetic nephropathy in type 1 diabetic women. Diabetologia 2007, 50:516-522.
60. National Institute of Health and Clinical Excellence. Statins for the prevention of cardiovascular events. Technology appraisal 94. London: NICE; updated January 2006.
61. Williams D.J., Davison J.M. Chronic kidney disease in pregnancy. BMJ 2008, 336:211-215.
62. Reiter L., Brown M.A., Whitworth J.A. Hypertension in pregnancy: the incidence of underlying renal disease and essential hypertension. Am J Kidney Dis 1994, 24:883-887.
63. Romundstad S., Holmen J., Kvenild K., et al. Microalbuminuria and all-cause mortality in 2089 apparently healthy individuals: a 4.4 year follow-up study. The Nord-Trondelag Health Study (HUNT), Norway. Am J Kidney Dis 2003, 42:466-473.
64. Suzuki H., Watanabe Y., Arima H., et al. Short- and long-term prognosis of blood pressure and kidney disease in women with a past history of preeclampsia. Clin Exp Nephrol 2008, 12:102-109.
65. Vikse B.E., Irgenss L.M., Leivestad T., Skjaerven R., Iversen B.M. Preeclampsia and the risk of end-stage renal disease. N Engl J Med 2008, 359:800-809.
66. Robertson L., Wu O., Langhorne P., et al. Thrombophilia in pregnancy: a systematic review. Br J Haematol 2006, 132:171-196.
67. van Walraven C., Mamdani M., Cohn A., et al. Risk of thromboembolism for patients with pre-eclampsia. BMJ 2003, 326:791-799.
68. Kestenbaum B., Seliger S.L., Easterling T.R., et al. Cardiovascular and thromboembolic events following hypertensive pregnancy. Am J Kidney Dis 2003, 42:982-989.
69. Levine R.J., Vatten L.J., Horowitz G.L., et al. Pre-eclampsia, soluble fms-like tyrosine kinase 1, and the risk of reduced thyroid function: nested case-control and population based study. BMJ 2009, 339:b4336.
70. Kamba T., Tam B.Y., Hashizume H., et al. VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature. Am J Physiol Heart Circ Physiol 2006, 290:H560-H576.
71. Maynard S.E., Min J.Y., Merchan J., et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt-1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003, 111:649-658.
72. Yoshimatsu J., Matsumoto H., Goto K., Shimano M., Narahara H., Miyakawa I. Relationship between urinary albumin and serum soluble fms-like tyrosine kinase 1 (sFlt-1) in normal pregnancy. Eur J Obstet Gynecol Reprod Biol 2006, 128:204-208.
73. Do women with preeclampsia and their babies benefit from magnesium sulphate? The Magpie Trial: a randomized placebo controlled trial. Lancet 2002, 359. The MAGPIE Trial Collaborative Group, 1877-20.
74. Maharaj A.S.R., Saint-Geniez M., Maldonado A.E., D'Amore P.A. Vascular endothelial growth factor localization in the adult. Am J Pathol 2006, 168:639-648.
75. Brusse I., Duvekot J., Jongerling J., et al. Impaired maternal cognitive functioning after pregnancies complicated by severe pre-eclampsia: a pilot case-control study. Acta Obstet Gynecol 2008, 87:408-412.
76. Castles A., Adams E.K., Melvin C.L., et al. Effects of smoking during pregnancy. Five meta-analyses. Am J Prev Med 1999, 16:208-215.
77. Vatten L.J., Forman M.R., Nilsen T.I., et al. The negative association between pre-eclampsia and breast cancer risk may depend on the offspring's gender. Br J Cancer 2007, 96:1436-1438.
78. Cudmore M., Ahmad S., Al-Ani B., et al. Negative regulation of soluble Flt-1 and soluble endoglin release b hemeoxygenase-1. Circulation 2007, 115:1789-1797.
79. Barker D.J., Eriksson J.G., Forsen T., Osmond C. Fetal origins of adult disease: strength of effects and biological basis. Int J Epidemiol 2002, 31:1235-1239.
80. Wu C.S., Nohr E.A., Bech B.H., et al. Health of children born to mothers who had preeclampsia: a population-based cohort study. Am J Obstet Gynecol 2009, 201:269.e1-269.e10.